Physician profile
Roy Ruttiman
NPI 1760988125
$8,167.88
in general payments reported to CMS, 2019-2025
10 companies · $3,649 in 2025
The $3,649 reported for 2025 was more than what 82% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $428 · 2024: $4,091 · 2025: $3,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,085 · Travel and Lodging: $2,833 · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,085.02 |
| Travel and Lodging | $2,832.86 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,166.65 | 2024 | Indigo System |
| Boston Scientific Corporation | $2,892.10 | 2023-2025 | Obsidio, Embold Fibered, Therasphere Administration Set |
| W. L. Gore & Associates, INC. | $1,186.35 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Viatorr Tips Endoprosthesis W/ Controlled Expansion, Gore Viabahn Endoprosthesis |
| Stryker Corporation | $282.23 | 2023-2025 | Spinejack, Clottriever Bold Catheter, Flowtriever |
| Terumo Medical Corporation | $171.92 | 2023-2024 | Azur Cx Detachable, Glidewire |
| Bard Peripheral Vascular, INC. | $153.75 | 2024 | Trek |
| Medtronic, INC. | $133.63 | 2025 | Osteocool Rf Ablation System |
| Ethicon US, LLC | $131.12 | 2024 | Neuwave |
| Philips North America LLC | $36.77 | 2023 | |
| Teleflex LLC | $13.36 | 2024 | Vsi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Ruttiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.